Z-0609-06
Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered...
Biogenex Laboratories, Inc. / initiated 2006-02-09 / Terminated
Biogenex Laboratories began a recall of Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu Monoclonal Antibody... on . The reason FDA records is "Products produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0609-06
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Biogenex Laboratories, Inc.
- Product
- Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu Monoclonal Antibody, Automated; Model number: AM134-10MP; Lot Numbers: AM134P1005
- Product code
- MVC System, Test, Her-2/Neu, Ihc
- Reason for recall
- Products produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
- FDA root cause
- Other
- Action
- On 2/9/06, the firm issued letters via UPS to all of its consignees, informing them of the affected products and providing instructions on the recall.
- Quantity in commerce
- 1 unit
- Distribution
- Nationwide. Italy, and United Kingdom. The product was released for distribution to 21 consignees nationwide to CA, FL, GA, IA, IL, NC, NJ, NY, TX, VT, WA, and WI. One VA account: VA Medical Center, Gwen Levy, Bld. 500, Room 1238, 11301 Wilshire Blvd., Los Angeles, CA 90073. 2 overseas consignees distributed the product to Italy (Space Imports Export SPL, Via Ranzato, 12, 1-20128 Milano, Italy and United Kingdom (Launch Diagnosis, West Yoke Farm unit 11, Michaels, Lane, Sevenoaks, Kent, TN15 7EP United Kingdom
- Product codes and lots
- Lot Numbers: AM134P1005
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
